CVS Health upgraded at TD Cowen after insurer unveils 2025 Medicare Advantage plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Bernstein SocGen Group Upgrades Humana (HUM) to Outperform
October 8, 2024 5:50 AM EDTBernstein SocGen Group analyst Lance Wilkes upgraded Humana (NYSE: HUM) from Market Perform to Outperform with a price target of $308.00 (from $405.00).
The analyst comments "We are updating our model, decreasing our target price, but upgrading our rating to Outperform based on a view that risks are being incorporated into expectations and price, coupled with improving sector outlook and potential upside catalysts. Upgrading HUM, our investment thesis - We believe HUM is now an attractive... More
TD Cowen Downgrades Humana (HUM) to Hold
October 7, 2024 5:29 AM EDTTD Cowen analyst Gary Taylor downgraded Humana (NYSE: HUM) from Buy to Hold with a price target of $261.00 (from $402.00).
The analyst comments "We are downgrading Humana from a Buy to Hold rating. Despite MA plans' ability to reprice the business each year (and... More
